Azacitidine Combined With Venetoclax and ATRA in Newly Diagnosed AML
NCT05654194
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Interventions
DRUG:
Azacitidine Combined With Venetoclax and ATRA group
Sponsor
The First Affiliated Hospital of Soochow University